TTRX
Turn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.94
+8.10%Institutional positioning
13F filings over the trailing two quarters
New 14Increased 7Reduced 5Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SteelPeak Wealth, LLC | New Position | 249,456 | Jul 13, 2026 |
| IEQ CAPITAL, LLC | New Position | 227,396 | Aug 11, 2026 |
| DDFG, Inc | Increased | 107,829 | Jul 28, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 74,301 | Aug 13, 2026 |
| DDFG, INC | Increased | 70,534 | Apr 22, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 69,757 | May 15, 2026 |
| Wellington Shields & Co., LLC | Unchanged | 65,732 | Aug 10, 2026 |
| WELLINGTON SHIELDS & CO., LLC | Unchanged | 65,732 | May 4, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 60,551 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 49,450 | May 15, 2026 |
| BlackRock, Inc. | New Position | 38,591 | Aug 7, 2026 |
| Aaron Wealth Advisors LLC | New Position | 32,564 | Jul 16, 2026 |
| TAMAR SECURITIES, LLC | Increased | 30,000 | May 14, 2026 |
| Tamar Securities, LLC | Unchanged | 30,000 | Aug 5, 2026 |
| ROYAL BANK OF CANADA | New Position | 28,250 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings